Logo del repository
  1. Home
 
Opzioni

Combining drug and psychological treatments for Obsessive-Compulsive Disorder: what is the evidence, when and for whom

Albert, Umberto
•
Salvo, Gabriele Di
•
Solia, Francesca
altro
Maina, Giuseppe
2018
  • journal article

Periodico
CURRENT MEDICINAL CHEMISTRY
Abstract
BACKGROUND: Serotonin reuptake inhibitors (SRIs) and cognitive-behavioral psychotherapy (CBT) are first-line treatments for obsessive-compulsive disorder (OCD). Since response is often inadequate, in recent years researchers investigated whether combining CBT and SRIs, either ab initio or sequentially, results in a greater reduction of obsessive-compulsive symptoms. OBJECTIVE: The aims of the present paper are to assess if combination treatment seems adding benefits as compared to either monotherapy alone and if sequential strategies may be effective in converting partial or non responders to a first-line treatment into responders. METHOD: We reviewed available literature on pharmacological and CBT combination and sequential treatments for adult and pediatric OCD patients and then we conducted a separate analysis for studies concerning these two promising strategies. Search results included open label trials and randomized controlled trials (RCTs). RESULTS: We identified ten controlled studies assessing the efficacy of combination treatments ab initio versus CBT alone and six evaluating combination strategies ab initio versus medications alone. Eleven studies, only two of which were RCTs, have been published on sequential treatments. The combination ab initio of CBT and SRIs has not been found to be clearly superior to either monotherapy alone in most studies conducted on this topic, except for patients with severe depression who might benefit more from the combination versus only CBT. A sequential administration of CBT after medications has been found useful in promoting remission in patients who partially responded to drugs and in promoting response in resistant patients. CONCLUSION: OCD patients with comorbid major depression should receive medication firstly, eventually associated with CBT; for all remaining patients there is clear evidence from the literature of no additive benefits of combining ab initio CBT and medication. Therefore, the routine use of a combination approach in all adult patients affected by OCD is not supported by the literature. The available evidence supports the effectiveness of the sequential addition of CBT to SRIs.
DOI
10.2174/0929867324666170712114445
WOS
WOS:000457318600001
Archivio
http://hdl.handle.net/11368/2957846
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85061597389
http://www.eurekaselect.com/154163/article
Diritti
closed access
license:copyright editore
FVG url
https://arts.units.it/request-item?handle=11368/2957846
Soggetti
  • Obsessive-Compulsive ...

  • augmentation treatmen...

  • cognitive behavioral ...

  • combination treatment...

  • exposure and response...

  • serotonin reuptake in...

  • treatment-resistant O...

Scopus© citazioni
5
Data di acquisizione
Jun 7, 2022
Vedi dettagli
Web of Science© citazioni
6
Data di acquisizione
Mar 26, 2024
google-scholar
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your nstitution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Realizzato con Software DSpace-CRIS - Estensione mantenuta e ottimizzata da 4Science

  • Impostazioni dei cookie
  • Informativa sulla privacy
  • Accordo con l'utente finale
  • Invia il tuo Feedback